MediPal Holdings Corporation (MAHLY)

Market Cap	3.76B +22.1%
Revenue (ttm)	24.08B +3.4%
Net Income	264.40M -16.1%
EPS	1.28 -15.2%
Shares Out	n/a
PE Ratio	14.22
Forward PE	n/a
Dividend	0.42 (2.35%)
Ex-Dividend Date	Mar 30, 2026

Volume	163
Average Volume	802
Open	17.68
Previous Close	n/a
Day's Range	17.68 - 17.68
52-Week Range	14.60 - 20.35
Beta	-0.10
RSI	49.13
Earnings Date	May 13, 2026

About MediPal Holdings

Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprising medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is also involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; and animal health product...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1898
• Employees: 13,061
• Stock Exchange: OTCMKTS
• Ticker Symbol: MAHLY

Financial Performance

In fiscal year 2025, MediPal Holdings's revenue was 3.67 trillion, an increase of 3.16% compared to the previous year's 3.56 trillion. Earnings were 40.28 billion, a decrease of -2.88%.

Financial numbers in JPY